review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0959-8049(11)70142-3 |
P698 | PubMed publication ID | 21944030 |
P2093 | author name string | Miranda F Ernst | |
Jetske Ruiterkamp | |||
P2860 | cites work | Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients | Q24806202 |
Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates | Q30872798 | ||
Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data | Q30967346 | ||
The role of surgery in the management of solitary pulmonary nodule in breast cancer patients | Q79699195 | ||
Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients | Q79765535 | ||
Surgical removal of primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease | Q79787098 | ||
Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival | Q79954604 | ||
Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment | Q80092296 | ||
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial | Q80495823 | ||
Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases | Q80516622 | ||
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer | Q81098394 | ||
Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer | Q81312783 | ||
Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis | Q81353372 | ||
Favourable long-term results after surgical removal of lung metastases of breast cancer | Q81360405 | ||
Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients | Q81528236 | ||
Surgery for pulmonary nodules in breast cancer patients | Q81690428 | ||
Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy | Q82056334 | ||
Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer | Q82758446 | ||
Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients | Q82847059 | ||
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands | Q83219611 | ||
Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis | Q83349364 | ||
Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis | Q83737832 | ||
Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure | Q84384384 | ||
Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up | Q73816218 | ||
[Hepatic resection for breast cancer metastases: results and prognosis (65 cases)] | Q74182360 | ||
Thermoradiotherapy for locally recurrent breast cancer with skin involvement | Q74262293 | ||
Long-term follow-up of a randomized trial on adjuvant chemotherapy and hormonal therapy in locally advanced breast cancer | Q74601289 | ||
Radiation therapy for chest wall recurrence of breast cancer after mastectomy in a favorable subgroup of patients | Q77525781 | ||
Does aggressive local therapy improve survival in metastatic breast cancer? | Q78449283 | ||
Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients | Q33284025 | ||
Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data | Q33285612 | ||
Repeated chemoembolization followed by laser-induced thermotherapy for liver metastasis of breast cancer. | Q33778000 | ||
Is breast cancer survival improving? | Q34285880 | ||
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer | Q34398320 | ||
Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial | Q34444401 | ||
An attempt to clarify indications for hepatectomy for liver metastases from breast cancer | Q35057199 | ||
A role for curative surgery in the treatment of selected patients with metastatic breast cancer | Q35139625 | ||
International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? | Q35820247 | ||
Stage IV breast cancer in the era of targeted therapy: does surgery of the primary tumor matter? | Q35860886 | ||
The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients | Q35976141 | ||
Management of bone metastases in breast cancer | Q36046266 | ||
The use of radiofrequency in cancer | Q36116078 | ||
Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. | Q36160476 | ||
Surgical treatment strategies and outcome in patients with breast cancer metastatic to the spine: a review of 87 patients | Q36384461 | ||
Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor | Q36449271 | ||
Systemic treatments for inflammatory breast cancer. | Q36492965 | ||
The role of external beam radiotherapy in the management of bone metastases | Q36682987 | ||
Point: Hyperthermia with radiation for chest wall recurrences | Q36794038 | ||
Surgical resection of the primary tumor is associated with increased long-term survival in patients with stage IV breast cancer after controlling for site of metastasis | Q36905539 | ||
Radiofrequency ablation in the management of liver metastases from breast cancer | Q36947866 | ||
Timing of surgical intervention for the intact primary in stage IV breast cancer patients | Q37115503 | ||
Treatment of metastatic breast cancer: looking towards the future | Q37157576 | ||
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival | Q37200654 | ||
Matched pair analyses of stage IV breast cancer with or without resection of primary breast site | Q37251791 | ||
Impact of breast surgery on survival in patients with distant metastases at initial presentation: a systematic review of the literature | Q37655594 | ||
Axillary staging in the neoadjuvant setting | Q37709210 | ||
Locally advanced breast cancer: defining an optimum treatment regimen. | Q40730740 | ||
Effectiveness of mastectomy by response to induction chemotherapy for control in inflammatory breast carcinoma | Q41601181 | ||
Effects of surgical excision on survival of patients with stage IV breast cancer | Q43528967 | ||
Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience | Q43703303 | ||
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy | Q43724292 | ||
Surgical treatment for skeletal breast cancer metastases: a population-based study of 641 patients | Q43915926 | ||
The effect of systemic therapy on local-regional control in locally advanced breast cancer | Q44002831 | ||
The prognostic significance of late local recurrence after breast-conserving therapy | Q44212905 | ||
Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy | Q44219353 | ||
Management of locally advanced carcinoma of the breast. II. Inflammatory carcinoma. | Q44834877 | ||
The results of radiation therapy for isolated local regional recurrence after mastectomy | Q44908330 | ||
Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study | Q45101678 | ||
Effects of primary chemotherapy in conservative treatment of breast cancer patients with operable tumors larger than 3 cm. Results of a randomized trial in a single centre | Q45206850 | ||
Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancer | Q45229213 | ||
Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancer | Q45627568 | ||
Surgical resection of the primary tumor, chest wall control, and survival in women with metastatic breast cancer | Q45854680 | ||
Association of surgery with improved survival in stage IV breast cancer patients | Q46625611 | ||
The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases | Q46916364 | ||
Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis | Q47176205 | ||
Stereotactic radiosurgical treatment of cerebral metastases arising from breast cancer | Q48145774 | ||
Surgical treatment of 70 patients with brain metastases from breast carcinoma | Q48598959 | ||
Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. | Q48829522 | ||
Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. | Q50478606 | ||
Prognosis after treatment for loco-regional recurrence after mastectomy or breast conserving therapy in two randomised trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. | Q50563037 | ||
Percutaneous MR imaging-guided laser-induced thermotherapy of hepatic metastases. | Q51353165 | ||
Pulmonary metastases of breast cancer. When is resection indicated? | Q51681105 | ||
Clinical features of surgical resection for pulmonary metastasis from breast cancer. | Q51698102 | ||
Prognostic factors for recurrent breast cancer patients with an isolated, limited number of lung metastases and implications for pulmonary metastasectomy. | Q51766155 | ||
Is liver resection justified for patients with hepatic metastases from breast cancer? | Q51775751 | ||
Role of postoperative radiation therapy after stabilization of fractures caused by metastatic disease. | Q52882024 | ||
Circulating tumor cells versus imaging--predicting overall survival in metastatic breast cancer. | Q53012804 | ||
Results of lung metastasectomy from breast cancer: prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. | Q53311270 | ||
CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer. | Q53408071 | ||
Multimodality therapy in inflammatory breast cancer: is there a place for surgery? | Q53769598 | ||
Presentation, management and outcome of axillary recurrence from breast cancer. | Q54027013 | ||
The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures | Q59721943 | ||
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: Results from five randomized controlled trials | Q60594506 | ||
Reoperation for locally recurrent breast cancer in patients previously treated with conservative surgery | Q62128623 | ||
Uncertain benefit from surgery in patients with lung metastases from breast carcinoma | Q62785649 | ||
Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma | Q63353119 | ||
Isolated local-regional recurrence following mastectomy for adenocarcinoma of the breast treated with radiation therapy alone or combined with surgery and/or chemotherapy | Q67941699 | ||
Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breast | Q68020168 | ||
Locally advanced breast cancer: the contribution of cytotoxic and endocrine treatment to radiotherapy. An EORTC Breast Cancer Co-operative Group Trial (10792) | Q69499715 | ||
Adjuvant chemotherapy (CMF) for stage III breast cancer: a randomized trial | Q69520541 | ||
The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy | Q69587568 | ||
Edema of the arm as a function of the extent of axillary surgery in patients with stage I-II carcinoma of the breast treated with primary radiotherapy | Q69619903 | ||
Inflammatory carcinoma of the breast: treatment results on 107 patients | Q69666333 | ||
Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation | Q69884400 | ||
Aggressive therapy for locoregional recurrence after mastectomy in stage II and III breast cancer patients | Q71116491 | ||
Mastectomy in the management of patients with inflammatory breast cancer | Q71801979 | ||
Hormonal therapy prolongs survival in irradiated locally advanced breast cancer: a European Organization for Research and Treatment of Cancer Randomized Phase III Trial | Q71975335 | ||
Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer | Q72616300 | ||
Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis | Q73292298 | ||
Salvage radiotherapy for local failures of lumpectomy and breast irradiation | Q73301116 | ||
Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer | Q73341194 | ||
Disease-free survival after resection of lung metastases in patients with breast cancer | Q73699135 | ||
Liver metastases from breast cancer: long-term survival after curative resection | Q73701691 | ||
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial | Q73792149 | ||
Surgical treatment of hepatic metastases from breast cancer | Q73806402 | ||
P921 | main subject | metastatic breast cancer | Q12859063 |
P304 | page(s) | S6-22 | |
P577 | publication date | 2011-09-01 | |
P1433 | published in | European Journal of Cancer | Q332260 |
P1476 | title | The role of surgery in metastatic breast cancer | |
P478 | volume | 47 Suppl 3 |
Q38029563 | A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study). |
Q92990842 | Carbon-ion radiotherapy for lymph node oligo-recurrence: a multi-institutional study by the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) |
Q55111538 | Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment. |
Q58752612 | Could local surgery improve survival in de novo stage IV breast cancer? |
Q35894515 | DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases |
Q30317067 | ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)† |
Q46896796 | First site of recurrence after breast cancer adjuvant treatment in the era of multimodality therapy: which imaging for which patient during follow-up? |
Q29248323 | Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study |
Q33823590 | Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases |
Q38677028 | Is Stereotactic Body Radiotherapy (SBRT) in lymph node oligometastatic patients feasible and effective? |
Q38576929 | Liver Ablation: Best Practice. |
Q37653376 | Liver resection for HER2-enriched breast cancer metastasis: case report and review of the literature |
Q38104240 | Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature. |
Q36198921 | Management of primary metastatic breast cancer in elderly patients--an international comparison of oncogeriatric versus standard care |
Q36702139 | Pathways to breast cancer recurrence. |
Q37625349 | Primary 4T1 tumor resection provides critical "window of opportunity" for immunotherapy |
Q92865310 | Primary Tumor Surgery for Patients with De Novo Stage IV Breast Cancer can Decrease Local Symptoms and Improve Quality of Life |
Q37386094 | Primary surgical treatment of locally advanced breast cancer in low resource settings |
Q36277982 | Progesterone regulates the proliferation of breast cancer cells - in vitro evidence |
Q58564534 | Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: a systematic review and meta-analysis |
Q86878792 | Radiofrequency thermal ablation (RFA) of hepatic metastases (METS) from breast cancer (BC): an adjunctive tool in the multimodal treatment of advanced disease |
Q33759443 | Radiotherapy in patients with distant metastatic breast cancer |
Q37937872 | Radiotherapy in patients with metastatic breast cancer |
Q47915753 | Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough. |
Q35758296 | Surgical resection of a liver metastasis from breast cancer |
Q92690953 | Survival benefit of radiotherapy after surgery in de novo stage IV breast cancer: a population-based propensity-score matched analysis |
Q38990182 | The impact of local treatment of the primary tumor site in node positive and metastatic prostate cancer patients |
Q38152342 | Thyroid metastasectomy |
Q36706395 | β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases |